These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
446 related articles for article (PubMed ID: 25265985)
1. Locations of acantholysis in pemphigus vulgaris and pemphigus foliaceus. Ohata C; Ishii N; Furumura M J Cutan Pathol; 2014 Nov; 41(11):880-9. PubMed ID: 25265985 [TBL] [Abstract][Full Text] [Related]
2. Pemphigus vulgaris: recent advances in our understanding of its pathogenesis. Femiano F Minerva Stomatol; 2007 Apr; 56(4):215-23. PubMed ID: 17452959 [TBL] [Abstract][Full Text] [Related]
3. Two cases of cutaneous-type pemphigus vulgaris and a case of pemphigus foliaceus without mucosal involvement despite high anti-desmoglein 3 autoantibody levels. Terada A; Akasaka E; Nakano H; Sawamura D J Dermatol; 2023 Nov; 50(11):1501-1505. PubMed ID: 37485682 [TBL] [Abstract][Full Text] [Related]
4. Ultrastructure of acantholysis in pemphigus foliaceus re-examined from the current perspective. van der Wier G; Jonkman MF; Pas HH; Diercks GF Br J Dermatol; 2012 Dec; 167(6):1265-71. PubMed ID: 22835262 [TBL] [Abstract][Full Text] [Related]
5. Antibodies to the amino-terminal domain of desmoglein 1 are retained during transition from pemphigus vulgaris to pemphigus foliaceus. España A; Koga H; Suárez-Fernández R; Ohata C; Ishii N; Irarrazaval I; Teye K; Ohyama B; Hashimoto T Eur J Dermatol; 2014; 24(2):174-9. PubMed ID: 24776707 [TBL] [Abstract][Full Text] [Related]
6. Desmoglein 1 and 3 enzyme-linked immunosorbent assay in Iranian patients with pemphigus vulgaris: correlation with phenotype, severity, and disease activity. Daneshpazhooh M; Chams-Davatchi C; Khamesipour A; Mansoori P; Taheri A; Firooz A; Mortazavi H; Esmaili N; Dowlati Y J Eur Acad Dermatol Venereol; 2007 Nov; 21(10):1319-24. PubMed ID: 17958835 [TBL] [Abstract][Full Text] [Related]
7. Evaluation of sensitivity and specificity of enzyme-linked immunosorbent assay (ELISA) for detecting antidesmoglein 1 and 3 in Thai patients with pemphigus vulgaris and foliaceus. Kulkollakarn S; Wattanakrai P; Vachiramon V; Chalidapongse P J Med Assoc Thai; 2008 Nov; 91(11):1663-8. PubMed ID: 19127786 [TBL] [Abstract][Full Text] [Related]
8. [Detection of serum desmoglein antibody level using enzyme-linked immunosorbent assay (ELISA) for monitoring disease activity in patients with pemphigus vulgaris]. Zhong S; Qiu YF; Han BB; Zhao JY; Zhu XJ; Chen XX Beijing Da Xue Xue Bao Yi Xue Ban; 2011 Jun; 43(3):414-5. PubMed ID: 21681274 [TBL] [Abstract][Full Text] [Related]
10. Using desmoglein 1 and 3 enzyme-linked immunosorbent assay as an adjunct diagnostic tool for pemphigus. Huang CH; Chen CC; Wang CJ; Chang YT; Liu HN J Chin Med Assoc; 2007 Feb; 70(2):65-70. PubMed ID: 17339147 [TBL] [Abstract][Full Text] [Related]
11. Clues to diagnosis for unusual mucosal pemphigus demonstrating undetectable anti-desmoglein 3 serum antibodies by routine tests. Kamiya K; Aoyama Y; Yamaguchi M; Ukida A; Mizuno-Ikeda K; Fujii K; Hamada T; Tokura Y; Iwatsuki K J Dermatol; 2015 Jun; 42(6):572-9. PubMed ID: 25832452 [TBL] [Abstract][Full Text] [Related]
12. Antibodies against keratinocyte antigens other than desmogleins 1 and 3 can induce pemphigus vulgaris-like lesions. Nguyen VT; Ndoye A; Shultz LD; Pittelkow MR; Grando SA J Clin Invest; 2000 Dec; 106(12):1467-79. PubMed ID: 11120754 [TBL] [Abstract][Full Text] [Related]
13. IgG-induced clustering of desmogleins 1 and 3 in skin of patients with pemphigus fits with the desmoglein nonassembly depletion hypothesis. Oktarina DA; van der Wier G; Diercks GF; Jonkman MF; Pas HH Br J Dermatol; 2011 Sep; 165(3):552-62. PubMed ID: 21692763 [TBL] [Abstract][Full Text] [Related]
14. Immunofluorescence and immunoblot studies on the reactivity of pemphigus vulgaris and pemphigus foliaceus sera with desmoglein 3 and desmoglein 1. Hashimoto T; Amagai M; Garrod DR; Nishikawa T Epithelial Cell Biol; 1995; 4(2):63-9. PubMed ID: 8688919 [TBL] [Abstract][Full Text] [Related]
15. Anti-Desmoglein 1 and 3 Autoantibody Levels in Endemic Pemphigus Foliaceus and Pemphigus Vulgaris from Brazil. Oliveira LA; Marquart-Filho A; Trevilato G; Timoteo RP; Mukai M; Roselino AM; Petzl-Erler ML Clin Lab; 2016 Jul; 62(7):1209-1216. PubMed ID: 28164651 [TBL] [Abstract][Full Text] [Related]
16. The use of BIOCHIP technique in diagnosis of different types of pemphigus: Vulgaris and foliaceus. Adaszewska A; Kalinska-Bienias A; Jagielski P; Wozniak K; Kowalewski C J Immunol Methods; 2019 May; 468():35-39. PubMed ID: 30910537 [TBL] [Abstract][Full Text] [Related]
17. Factors associated with non-pathogenic antibodies against desmoglein-3 in pemphigus foliaceus. Vernal S; Julio TA; Alves FH; Turatti A; Donadi EA; Roselino AM An Bras Dermatol; 2024; 99(5):680-687. PubMed ID: 38851894 [TBL] [Abstract][Full Text] [Related]
18. Prolonged clinical remission of patients with severe pemphigus upon rapid removal of desmoglein-reactive autoantibodies by immunoadsorption. Eming R; Rech J; Barth S; Kalden JR; Schuler G; Harrer T; Hertl M Dermatology; 2006; 212(2):177-87. PubMed ID: 16484825 [TBL] [Abstract][Full Text] [Related]
19. Explanations for the clinical and microscopic localization of lesions in pemphigus foliaceus and vulgaris. Mahoney MG; Wang Z; Rothenberger K; Koch PJ; Amagai M; Stanley JR J Clin Invest; 1999 Feb; 103(4):461-8. PubMed ID: 10021453 [TBL] [Abstract][Full Text] [Related]
20. Usefulness of specific anti-desmoglein 1 and 3 enzyme-linked immunoassay and indirect immunofluorescence in the evaluation of pemphigus activity. Barnadas MA; Rubiales MV; Gich I; Gelpí C Int J Dermatol; 2015 Nov; 54(11):1261-8. PubMed ID: 25754029 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]